🔎 Trials Near Me

Home › Non-Muscle Invasive Bladder Cancer › Arizona

Non-Muscle Invasive Bladder Cancer clinical trials in Arizona

9 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Arizona.

Cities in Arizona

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Banner MD Anderson Cancer Center, Gilbert
  • Mayo Clinic Hospital in Arizona, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

  • Academic Urology and Urogynecology of Arizona, Sun City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Mayo Clinic, Phoenix
  • East Valley Urology Center of Arizona, Queen Creek
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • East Valley Urology Center of Arizona, Queen Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • University of Arizona - Cancer Center, Tucson
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • Mayo Clinic, Scottsdale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

  • East Valley Urology Center of Arizona, Mesa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT05710848

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

  • Arizona Clinical Trials, Chandler
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Mar 27, 2026 · NCT06800963

Blue Light Cystoscopy With Cysview® Registry

  • Mayo Clinic, Phoenix
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT02660645

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.